Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co Other Financing Chart
Genertec Universal Medical Group Co Other Financing Calculation
Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges
Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1,922 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Financing of HK$-1,922 Mil mean?
Genertec Universal Medical Group Co (HKSE:02666) has a Other Financing of HK$-1,922 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Genertec Universal Medical Group Co and its competitors.
Is Genertec Universal Medical Group Co's Other Financing too high?
Genertec Universal Medical Group Co's current Other Financing is HK$-1,922 Mil. Overall, Genertec Universal Medical Group Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genertec Universal Medical Group Co's Other Financing compare to V and MA?
Genertec Universal Medical Group Co's Other Financing of HK$-1,922 Mil can be compared against companies in the Credit Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Credit Services company?
A good Other Financing depends on the Credit Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Genertec Universal Medical Group Co and its competitors. Genertec Universal Medical Group Co's current Other Financing is HK$-1,922 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genertec Universal Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co (HKSE:02666) is currently considered Fairly Valued. The stock's GF Value™ is HK$4.51, compared to a current price of HK$4.67 — trading 3.5% above its estimated fair value. The current Other Financing is HK$-1,922 Mil. Genertec Universal Medical Group Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Genertec Universal Medical Group Co (HKSE:02666), the current Other Financing is HK$-1,922 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genertec Universal Medical Group Co (HKSE:02666) Overvalued in 2026?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co stock appears to be overvalued.
The current stock price of HK$4.67 is trading 3.5% above its estimated GF Value™ of HK$4.51.
GuruFocus considers Genertec Universal Medical Group Co to be Fairly Valued.
Key valuation signals for HKSE:02666:
Other Financing: HK$-1,922 Mil
GF Value™: HK$4.51 vs. price of HK$4.67 (3.5% above fair value)
No single metric tells the full story. See the HKSE:02666 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The group has two business segments namely The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services; and Healthcare business comprises includes hospital group business, healthcare technology business and specialty business. Geographically, it derives a majority of its revenue from Mainland China.
84GF Score
Get the complete analysis for HKSE:02666
Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02666 has been successfully added to your 
